{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T03:36:51Z","timestamp":1770089811407,"version":"3.49.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405614"],"award-info":[{"award-number":["82405614"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471704"],"award-info":[{"award-number":["82471704"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274575"],"award-info":[{"award-number":["82274575"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M761879"],"award-info":[{"award-number":["2024M761879"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2025MS1212"],"award-info":[{"award-number":["ZR2025MS1212"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022LZY011"],"award-info":[{"award-number":["ZR2022LZY011"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QC167"],"award-info":[{"award-number":["ZR2023QC167"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH452"],"award-info":[{"award-number":["ZR2023QH452"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Basic Research Project of Shandong Natural Science Foundation","award":["ZR2023ZD56"],"award-info":[{"award-number":["ZR2023ZD56"]}]},{"name":"Co-construction project of State Administration of TCM","award":["GZY-KJS-SD-2023-034"],"award-info":[{"award-number":["GZY-KJS-SD-2023-034"]}]},{"name":"Taishan Scholars Program","award":["tstp20240513"],"award-info":[{"award-number":["tstp20240513"]}]},{"name":"Central Government Guides Local Science and Technology Development Fund Projects of Shandong Province","award":["YDZX20203700001407"],"award-info":[{"award-number":["YDZX20203700001407"]}]},{"name":"Key Laboratory of Traditional Chinese Medicine Classical Theory, Ministry of Education, Open Research Project"},{"name":"National Youth Qihuang Scholar Training Program and Shandong Province Traditional Chinese Medicine High Level Talent Cultivation Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04363-5","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T15:54:32Z","timestamp":1767196472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pan cohort immune biomarker of CD8 lymphocyte activation enabling HGSOC outcome prediction and treatment response"],"prefix":"10.1007","volume":"17","author":[{"given":"Xinkui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nannan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruohan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoqiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siambi","family":"Kikete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangzhong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiarui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"issue":"1","key":"4363_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"4363_CR2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41568-022-00503-z","volume":"22","author":"LE Kandalaft","year":"2022","unstructured":"Kandalaft LE, Dangaj Laniti D, Coukos G. Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation. Nat Rev Cancer. 2022;22(11):640\u201356.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"4363_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"S Vaughan","year":"2011","unstructured":"Vaughan S, Coward JI, Bast RC Jr., et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer. 2011;11(10):719\u201325.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"4363_CR4","first-page":"284","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, Desantis CE, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284\u201396.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"4363_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrclinonc.2015.224","volume":"13","author":"S Narod","year":"2016","unstructured":"Narod S. Can advanced-stage ovarian cancer be cured? Nat Rev Clin Oncol. 2016;13(4):255\u201361.","journal-title":"Nat Rev Clin Oncol"},{"key":"4363_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.semcancer.2020.08.017","volume":"77","author":"O Le Saux","year":"2021","unstructured":"Le Saux O, Ray-Coquard I, Labidi-Galy SI. Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer. Semin Cancer Biol. 2021;77:127\u201343.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"4363_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/cmi.2016.7","volume":"15","author":"N Ueda","year":"2018","unstructured":"Ueda N, Zhang R, Tatsumi M, et al. BCR-ABL-specific CD4(+) T-helper cells promote the priming of antigen-specific cytotoxic T cells via dendritic cells. Cell Mol Immunol. 2018;15(1):15\u201326.","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"4363_CR8","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.ccell.2021.10.008","volume":"39","author":"J Duraiswamy","year":"2021","unstructured":"Duraiswamy J, Turrini R, Minasyan A, et al. Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation. Cancer Cell. 2021;39(12):1623-1642 e20.","journal-title":"Cancer Cell"},{"issue":"51","key":"4363_CR9","doi-asserted-by":"publisher","first-page":"18538","DOI":"10.1073\/pnas.0509182102","volume":"102","author":"E Sato","year":"2005","unstructured":"Sato E, Olson S, Ahn J, et al. Intraepithelial CD8\u2009+\u2009tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A. 2005;102(51):18538\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"4363_CR10","doi-asserted-by":"publisher","first-page":"e173290","DOI":"10.1001\/jamaoncol.2017.3290","volume":"3","author":"OTT Analysis","year":"2017","unstructured":"Analysis OTT, Goode C, Block EL. Dose-response association of CD8\u2009+\u2009Tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer. JAMA Oncol. 2017;3(12):e173290.","journal-title":"JAMA Oncol"},{"issue":"12","key":"4363_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100856","volume":"3","author":"B Yang","year":"2022","unstructured":"Yang B, Li X, Zhang W, et al. Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis. Cell Rep Med. 2022;3(12): 100856.","journal-title":"Cell Rep Med"},{"issue":"7","key":"4363_CR12","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ccell.2021.04.004","volume":"39","author":"M Hornburg","year":"2021","unstructured":"Hornburg M, Desbois M, Lu S, et al. Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer. Cancer Cell. 2021;39(7):928-944 e6.","journal-title":"Cancer Cell"},{"issue":"8","key":"4363_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm1831","volume":"8","author":"K Zhang","year":"2022","unstructured":"Zhang K, Erkan E, Jamalzadeh S, et al. Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer. Sci Adv. 2022;8(8):eabm1831.","journal-title":"Sci Adv"},{"issue":"34","key":"4363_CR14","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1200\/JCO.2015.62.3397","volume":"33","author":"J Hamanishi","year":"2015","unstructured":"Hamanishi J, Mandai M, Ikeda T, et al. Safety and antitumor activity of anti-PD-1 antibody, nivolumab, in patients with platinum-resistant ovarian cancer. J Clin Oncol. 2015;33(34):4015\u201322.","journal-title":"J Clin Oncol"},{"issue":"7","key":"4363_CR15","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/annonc\/mdz135","volume":"30","author":"UA Matulonis","year":"2019","unstructured":"Matulonis UA, Shapira-Frommer R, Santin AD, et al. Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study. Ann Oncol. 2019;30(7):1080\u20137.","journal-title":"Ann Oncol"},{"issue":"Suppl 24","key":"4363_CR16","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1002\/cncr.32520","volume":"125","author":"A Gonzalez-Martin","year":"2019","unstructured":"Gonzalez-Martin A, Sanchez-Lorenzo L. Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: still promising? Cancer. 2019;125(Suppl 24):4616\u201322.","journal-title":"Cancer"},{"issue":"5","key":"4363_CR17","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1158\/1078-0432.CCR-11-2725","volume":"18","author":"K Yoshihara","year":"2012","unstructured":"Yoshihara K, Tsunoda T, Shigemizu D, et al. High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway. Clin Cancer Res. 2012;18(5):1374\u201385.","journal-title":"Clin Cancer Res"},{"issue":"16","key":"4363_CR18","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","volume":"14","author":"RW Tothill","year":"2008","unstructured":"Tothill RW, Tinker AV, George J, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res. 2008;14(16):5198\u2013208.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4363_CR19","doi-asserted-by":"publisher","first-page":"e9615","DOI":"10.1371\/journal.pone.0009615","volume":"5","author":"K Yoshihara","year":"2010","unstructured":"Yoshihara K, Tajima A, Yahata T, et al. Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets. PLoS One. 2010;5(3):e9615.","journal-title":"PLoS One"},{"issue":"8","key":"4363_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4363_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400-416 e11.","journal-title":"Cell"},{"issue":"3","key":"4363_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier L, Cope L, Bolstad B, et al. Affy\u2013analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20(3):307\u201315.","journal-title":"Bioinformatics"},{"issue":"7","key":"4363_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"4363_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz114","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao Y, Smyth GK, Shi W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 2019;47(8):e47.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4363_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"key":"4363_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"9","key":"4363_CR27","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53(9):1334\u201347.","journal-title":"Nat Genet"},{"key":"4363_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"24","key":"4363_CR29","doi-asserted-by":"publisher","first-page":"6238","DOI":"10.1158\/0008-5472.CAN-18-3560","volume":"79","author":"A Jim\u00e9nez-S\u00e1nchez","year":"2019","unstructured":"Jim\u00e9nez-S\u00e1nchez A, Cast O, Miller ML. Comprehensive benchmarking and integration of tumor microenvironment cell estimation methods. Cancer Res. 2019;79(24):6238\u201346.","journal-title":"Cancer Res"},{"key":"4363_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1070-5","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016. https:\/\/doi.org\/10.1186\/s13059-016-1070-5.","journal-title":"Genome Biol"},{"key":"4363_CR31","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.26476","author":"J Racle","year":"2017","unstructured":"Racle J, De Jonge K, Baumgaertner P, et al. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife. 2017. https:\/\/doi.org\/10.7554\/eLife.26476.","journal-title":"Elife"},{"issue":"1","key":"4363_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello F, Mayer C, Plattner C, et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019;11(1):34.","journal-title":"Genome Med"},{"key":"4363_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1028-7","author":"B Li","year":"2016","unstructured":"Li B, Severson E, Pignon J-C, et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016. https:\/\/doi.org\/10.1186\/s13059-016-1028-7.","journal-title":"Genome Biol"},{"issue":"12","key":"4363_CR34","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"key":"4363_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep06207","volume":"4","author":"Y Senbabaoglu","year":"2014","unstructured":"Senbabaoglu Y, Michailidis G, Li JZ. Critical limitations of consensus clustering in class discovery. Sci Rep. 2014;4:6207.","journal-title":"Sci Rep"},{"key":"4363_CR36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"4363_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","volume":"39","author":"N Simon","year":"2011","unstructured":"Simon N, Friedman J, Hastie T, et al. Regularization paths for Cox\u2019s proportional hazards model via coordinate descent. J Stat Softw. 2011;39(5):1\u201313.","journal-title":"J Stat Softw"},{"issue":"11","key":"4363_CR38","doi-asserted-by":"publisher","first-page":"e1195","DOI":"10.1371\/journal.pone.0001195","volume":"2","author":"O Hofmann","year":"2007","unstructured":"Hofmann O, Hoshida Y, Brunet J-P, et al. Subclass mapping: identifying common subtypes in independent disease data sets. PLoS ONE. 2007;2(11):e1195.","journal-title":"PLoS ONE"},{"issue":"10","key":"4363_CR39","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"issue":"9","key":"4363_CR40","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"JD Barbour","year":"2014","unstructured":"Barbour JD, Geeleher P, Cox N, et al. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE. 2014;9(9):e107468.","journal-title":"PLoS ONE"},{"issue":"11","key":"4363_CR41","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin D-C, Assenov Y, et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356.","journal-title":"Genome Res"},{"issue":"1","key":"4363_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","volume":"23","author":"TA Knijnenburg","year":"2018","unstructured":"Knijnenburg TA, Wang L, Zimmermann MT, et al. Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas. Cell Rep. 2018;23(1):239-254.e6.","journal-title":"Cell Rep"},{"issue":"8","key":"4363_CR43","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s43018-023-00599-8","volume":"4","author":"X Zheng","year":"2023","unstructured":"Zheng X, Wang X, Cheng X, et al. Single-cell analyses implicate Ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer. Nat Cancer. 2023;4(8):1138\u201356.","journal-title":"Nat Cancer"},{"issue":"13","key":"4363_CR44","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573-3587.e29.","journal-title":"Cell"},{"key":"4363_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1874-1","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister C, Satija R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 2019. https:\/\/doi.org\/10.1186\/s13059-019-1874-1.","journal-title":"Genome Biol"},{"issue":"5","key":"4363_CR46","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nbt.4091","volume":"36","author":"L Haghverdi","year":"2018","unstructured":"Haghverdi L, Lun ATL, Morgan MD, et al. Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors. Nat Biotechnol. 2018;36(5):421\u20137.","journal-title":"Nat Biotechnol"},{"key":"4363_CR47","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","volume":"19","author":"M Andreatta","year":"2021","unstructured":"Andreatta M, Carmona SJ. UCell: robust and scalable single-cell gene signature scoring. Comput Struct Biotechnol J. 2021;19:3796\u20138.","journal-title":"Comput Struct Biotechnol J"},{"key":"4363_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","journal-title":"Nat Commun"},{"key":"4363_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah3560","author":"W Roh","year":"2017","unstructured":"Roh W, Chen P-L, Reuben A, et al. Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aah3560.","journal-title":"Sci Transl Med"},{"issue":"4","key":"4363_CR50","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/cas.14340","volume":"111","author":"S Nishio","year":"2020","unstructured":"Nishio S, Matsumoto K, Takehara K, et al. Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: subgroup analysis from the KEYNOTE-100. Cancer Sci. 2020;111(4):1324\u201332.","journal-title":"Cancer Sci"},{"key":"4363_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005147","author":"RE Sanborn","year":"2022","unstructured":"Sanborn RE, Pishvaian MJ, Callahan MK, et al. Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1136\/jitc-2022-005147.","journal-title":"J Immunother Cancer"},{"issue":"7","key":"4363_CR52","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/S1470-2045(21)00216-3","volume":"22","author":"E Pujade-Lauraine","year":"2021","unstructured":"Pujade-Lauraine E, Fujiwara K, Ledermann JA, et al. Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study. Lancet Oncol. 2021;22(7):1034\u201346.","journal-title":"Lancet Oncol"},{"key":"4363_CR53","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.3343","author":"JF Liu","year":"2019","unstructured":"Liu JF, Herold C, Gray KP, et al. Assessment of combined nivolumab and bevacizumab in relapsed ovarian cancer. JAMA Oncol. 2019. https:\/\/doi.org\/10.1001\/jamaoncol.2019.3343.","journal-title":"JAMA Oncol"},{"key":"4363_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1045957","author":"Y Xu","year":"2022","unstructured":"Xu Y, Zuo F, Wang H, et al. The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.1045957.","journal-title":"Front Immunol"},{"issue":"3","key":"4363_CR55","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang L, Conejo-Garcia J, Katsaros D, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003;348(3):203\u201313.","journal-title":"N Engl J Med"},{"issue":"3","key":"4363_CR56","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/modpathol.2008.191","volume":"22","author":"B Clarke","year":"2009","unstructured":"Clarke B, Tinker AV, Lee C-H, et al. Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss. Mod Pathol. 2009;22(3):393\u2013402.","journal-title":"Mod Pathol"},{"issue":"27","key":"4363_CR57","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.1038\/s41388-020-1348-7","volume":"39","author":"S Yu","year":"2020","unstructured":"Yu S, Yu X, Sun L, et al. GBP2 enhances glioblastoma invasion through Stat3\/fibronectin pathway. Oncogene. 2020;39(27):5042\u201355.","journal-title":"Oncogene"},{"issue":"4","key":"4363_CR58","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12282-012-0404-8","volume":"21","author":"P Godoy","year":"2012","unstructured":"Godoy P, Cadenas C, Hellwig B, et al. Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response. Breast Cancer. 2012;21(4):491\u20139.","journal-title":"Breast Cancer"},{"key":"4363_CR59","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004302","author":"H Wang","year":"2022","unstructured":"Wang H, Zhou Y, Zhang Y, et al. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1136\/jitc-2021-004302.","journal-title":"J Immunother Cancer"},{"key":"4363_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-016-0285-0","author":"X Wang","year":"2016","unstructured":"Wang X, Wang S-S, Zhou L, et al. A network-pathway based module identification for predicting the prognosis of ovarian cancer patients. J Ovarian Res. 2016. https:\/\/doi.org\/10.1186\/s13048-016-0285-0.","journal-title":"J Ovarian Res"},{"issue":"6","key":"4363_CR61","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.18632\/aging.102914","volume":"12","author":"Q Ding","year":"2020","unstructured":"Ding Q, Dong S, Wang R, et al. A nine-gene signature related to tumor microenvironment predicts overall survival with ovarian cancer. Aging. 2020;12(6):4879\u201395.","journal-title":"Aging"},{"key":"4363_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1176103","author":"Z Chen","year":"2023","unstructured":"Chen Z, Yin M, Jia H, et al. ISG20 stimulates anti-tumor immunity via a double-stranded RNA-induced interferon response in ovarian cancer. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1176103.","journal-title":"Front Immunol"},{"issue":"22","key":"4363_CR63","doi-asserted-by":"publisher","first-page":"8222","DOI":"10.1002\/cam4.4317","volume":"10","author":"D Zhang","year":"2021","unstructured":"Zhang D, Li Y, Yang S, et al. Identification of a glycolysis-related gene signature for survival prediction of ovarian cancer patients. Cancer Med. 2021;10(22):8222\u201337.","journal-title":"Cancer Med"},{"key":"4363_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02045-0","author":"J Yu","year":"2021","unstructured":"Yu J, Liu T-T, Liang L-L, et al. Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer. Cancer Cell Int. 2021. https:\/\/doi.org\/10.1186\/s12935-021-02045-0.","journal-title":"Cancer Cell Int"},{"key":"4363_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.894718","author":"Z Wang","year":"2022","unstructured":"Wang Z, Chen G, Dai F, et al. Identification and verification of necroptosis-related gene signature with prognosis and tumor immune microenvironment in ovarian cancer. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.894718.","journal-title":"Front Immunol"},{"issue":"10","key":"4363_CR66","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1172\/JCI25673","volume":"116","author":"L Vogt","year":"2006","unstructured":"Vogt L, Schmitz N, Kurrer MO, et al. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. J Clin Invest. 2006;116(10):2817\u201326.","journal-title":"J Clin Invest"},{"key":"4363_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02502-4","author":"L Liang","year":"2022","unstructured":"Liang L, Li J, Yu J, et al. Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer. Cancer Cell Int. 2022. https:\/\/doi.org\/10.1186\/s12935-022-02502-4.","journal-title":"Cancer Cell Int"},{"issue":"19","key":"4363_CR68","doi-asserted-by":"publisher","first-page":"23210","DOI":"10.18632\/aging.203613","volume":"13","author":"Q Tan","year":"2021","unstructured":"Tan Q, Liu H, Xu J, et al. Integrated analysis of tumor-associated macrophage infiltration and prognosis in ovarian cancer. Aging. 2021;13(19):23210\u201332.","journal-title":"Aging"},{"key":"4363_CR69","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003973","author":"L Long","year":"2021","unstructured":"Long L, Hu Y, Long T, et al. Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer. J Immunother Cancer. 2021. https:\/\/doi.org\/10.1136\/jitc-2021-003973.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"4363_CR70","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12079-021-00633-3","volume":"16","author":"A Aravind","year":"2021","unstructured":"Aravind A, Palollathil A, Rex D, a B, et al. A multi-cellular molecular signaling and functional network map of C\u2013C motif chemokine ligand 18 (CCL18): a chemokine with immunosuppressive and pro-tumor functions. J Cell Communication Signal. 2021;16(2):293\u2013300.","journal-title":"J Cell Communication Signal"},{"key":"4363_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.941556","author":"H Ji","year":"2022","unstructured":"Ji H, Liu Z, Wang F, et al. Novel macrophage-related gene prognostic index for glioblastoma associated with M2 macrophages and T cell dysfunction. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.941556.","journal-title":"Front Immunol"},{"issue":"1","key":"4363_CR72","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1158\/1055-9965.EPI-22-0877","volume":"32","author":"CA Hathaway","year":"2023","unstructured":"Hathaway CA, Wang T, Townsend MK, et al. Lifetime exposure to cigarette smoke and risk of ovarian cancer by T-cell tumor immune infiltration. Cancer Epidemiol Biomarkers Prev. 2023;32(1):66\u201373.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"4363_CR73","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ccell.2022.03.008","volume":"40","author":"CM Anadon","year":"2022","unstructured":"Anadon CM, Yu X, H\u00e4nggi K, et al. Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells. Cancer Cell. 2022;40(5):545-557.e13.","journal-title":"Cancer Cell"},{"issue":"9","key":"4363_CR74","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/cells7090133","volume":"7","author":"J Concetti","year":"2018","unstructured":"Concetti J, Wilson CL. NFKB1 and cancer: friend or foe? Cells. 2018;7(9):133.","journal-title":"Cells"},{"issue":"5","key":"4363_CR75","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.molimm.2009.11.016","volume":"47","author":"D Van De Wetering","year":"2010","unstructured":"Van De Wetering D, De Paus RA, Van Dissel JT, et al. Functional analysis of naturally occurring amino acid substitutions in human IFN-\u03b3R1. Mol Immunol. 2010;47(5):1023\u201330.","journal-title":"Mol Immunol"},{"issue":"9","key":"4363_CR76","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1158\/1078-0432.CCR-21-1762","volume":"28","author":"PF Peddi","year":"2022","unstructured":"Peddi PF, Fasching PA, Liu D, et al. Genetic polymorphisms and correlation with treatment-induced cardiotoxicity and prognosis in patients with breast cancer. Clin Cancer Res. 2022;28(9):1854\u201362.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4363_CR77","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCULATIONAHA.121.055801","volume":"145","author":"T Magdy","year":"2022","unstructured":"Magdy T, Jouni M, Kuo H-H, et al. Identification of drug transporter genomic variants and inhibitors that protect against doxorubicin-induced cardiotoxicity. Circulation. 2022;145(4):279\u201394.","journal-title":"Circulation"},{"issue":"13","key":"4363_CR78","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1200\/JCO.2010.34.3467","volume":"30","author":"H Visscher","year":"2012","unstructured":"Visscher H, Ross CJD, Rassekh SR, et al. Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol. 2012;30(13):1422\u20138.","journal-title":"J Clin Oncol"},{"key":"4363_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113818","author":"XB Shen","year":"2021","unstructured":"Shen XB, Chen X, Zhang ZY, et al. Cathepsin C inhibitors as anti-inflammatory drug discovery: challenges and opportunities. Eur J Med Chem. 2021. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113818.","journal-title":"Eur J Med Chem"},{"issue":"12","key":"4363_CR80","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nrc4027","volume":"15","author":"OC Olson","year":"2015","unstructured":"Olson OC, Joyce JA. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response. Nat Rev Cancer. 2015;15(12):712\u201329.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"4363_CR81","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00262-022-03288-0","volume":"72","author":"J Liu","year":"2022","unstructured":"Liu J, Chen H, Qiao G, et al. PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma. Cancer Immunol Immunother. 2022;72(4):881\u201393.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"4363_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1250-8","volume":"38","author":"H Shen","year":"2019","unstructured":"Shen H, He M, Lin R, et al. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR\/CCL2 pathway. J Exp Clin Cancer Res. 2019;38(1):247.","journal-title":"J Exp Clin Cancer Res"},{"key":"4363_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.768238","volume":"9","author":"G Wang","year":"2021","unstructured":"Wang G, Zhou Q, Xu Y, et al. Emerging roles of Pleckstrin-2 beyond cell spreading. Front Cell Dev Biol. 2021;9:768238.","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"4363_CR84","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/cac2.12349","volume":"42","author":"X Zhao","year":"2022","unstructured":"Zhao X, Shu D, Sun W, et al. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc\u2010mediated positive feedback loop. Cancer Commun. 2022;42(10):987\u20131007.","journal-title":"Cancer Commun"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04363-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04363-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04363-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:03:02Z","timestamp":1770040982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04363-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4363"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04363-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"199"}}